Results 51 to 60 of about 32,822 (166)

The Effect of Dual Antiplatelet Therapy on Bleeding, Transfusion, and Long-Term Outcomes After Transcatheter Aortic Valve Replacement

open access: yesThe Heart Surgery Forum
Background: Transcatheter aortic valve replacement (TAVR) has become an established treatment for severe aortic stenosis, offering a minimally invasive alternative to surgical aortic valve replacement.
Hunter Row   +6 more
doaj   +1 more source

Dual antiplatelet therapy

open access: yesDental Abstracts, 2016
Alice K. Jacobs, Zoran S. Nedeljkovic
openaire   +2 more sources

Dual antiplatelet therapy versus aspirin alone in acute ischemic stroke or transient ischemic attack: A meta-analysis and trial sequential analysis of randomized controlled trials

open access: yesJournal of International Medical Research
Introduction Data regarding the role of dual antiplatelet therapy in patients with ischemic stroke or transient ischemic attack are limited. This study aimed to systematically review and analyze the efficacy and safety of dual antiplatelet therapy ...
Ramez M Odat   +12 more
doaj   +1 more source

Dual Antiplatelet Therapy for Coronary Artery Disease

open access: yesCirculation Journal, 2015
Platelets initiate the formation of a thrombus at the site of an arterial injury, and the clotting cascade is activated as the thrombus matures. After coronary stent placement, dual antiplatelet therapy (DAPT) with aspirin and ticlopidine dramatically reduces the risk of stent thrombosis, compared with anticoagulation therapy, and has become the ...
openaire   +3 more sources

The Management of Combined Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Particularly Complex Challenge, Especially in the Elderly

open access: yesFrontiers in Physiology, 2018
Anticoagulation is superior to dual antiplatelet therapy (DAPT) in the prevention of thromboembolic events in patients with atrial fibrillation (AF), otherwise the prevention of ischemic risk and stent thrombosis after percutaneous coronary intervention (
Leonardo Bencivenga   +7 more
doaj   +1 more source

Real-world Data of Antithrombotic Therapy in Neuroendovascular Therapy: Analysis of JR-NET 4

open access: yesNeurologia Medico-Chirurgica
As the number of neuroendovascular therapies in Japan increases, the current trends in periprocedural antithrombotic therapy must be understood. We retrospectively analyzed data on periprocedural antithrombotic therapy in the Japanese Registry of ...
Nozomi SASAKI   +10 more
doaj   +1 more source

Cilostazol-based dual antiplatelet treatment in ischemic stroke or transient ischemic attack patients with asymptomatic carotid artery disease: a propensity score matching analysis

open access: yesFrontiers in Neurology
BackgroundThe optimal treatment for asymptomatic atherosclerotic carotid artery disease remains controversial. Data on the efficacy of antiplatelet agents and stroke outcomes are limited.
Thon Thiraworawong, Chadawan Pathonsmith
doaj   +1 more source

Perioperative Management of Dual Antiplatelet Therapy [PDF]

open access: yesJournal of Cardiothoracic and Vascular Anesthesia, 2018
Nicholas G, Kounis   +7 more
openaire   +2 more sources

Optimal Dual Antiplatelet Therapy Duration For Carotid Artery Stenting On the Basis of Angioscopic Findings

open access: yesStroke: Vascular and Interventional Neurology
Background Dual antiplatelet therapy plays a crucial role in preventing thrombosis in the perioperative period of carotid artery stenting (CAS); however, it has been associated with a risk of hemorrhagic complications. A standard regimen for the duration
Kenji Fukutome   +15 more
doaj   +1 more source

Effectiveness of Two-Year Versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis After Drug-Eluting Stent Implantation [PDF]

open access: yesJournal of Tehran University Heart Center, 2012
Background: Impact of 12 months’ versus 24 months’ use of dual antiplatelet therapy on the prevalence of stent thrombosis in patients undergoing percutaneous coronary intervention (PCI) with the drug-eluting stent (DES) is not clear.
Ali Reza Amirzadegan   +11 more
doaj  

Home - About - Disclaimer - Privacy